SATIVUS TECH CORP. Losses Widen Amid R&D Push, Going Concern Doubts

TL;DR

**SATT is bleeding cash with mounting losses and a 'going concern' warning; steer clear until they prove their saffron tech can actually turn a profit.**

AI Summary

SATIVUS TECH CORP. (SATT) reported a significant increase in net loss attributable to equity holders, reaching $266 thousand for the three months ended September 30, 2025, a substantial decline from a net profit of $2,070 thousand in the same period of 2024. For the nine months ended September 30, 2025, the net loss widened to $599 thousand from $554 thousand in the prior year. Operating expenses surged, with research and development increasing to $169 thousand from $93 thousand year-over-year for the quarter, and general and administrative expenses rising to $151 thousand from $62 thousand. The company's accumulated deficit grew to $24,207 thousand as of September 30, 2025, up from $23,608 thousand at December 31, 2024. Cash and cash equivalents increased to $159 thousand from $96 thousand, primarily due to $504 thousand in proceeds from the issuance of shares in a subsidiary and $36 thousand from convertible loans, offsetting a negative operating cash flow of $482 thousand for the nine months. Total current liabilities increased to $3,658 thousand from $3,228 thousand, driven by higher accounts payables and convertible loans. The company, through its 54%-owned subsidiary Saffron-Tech Ltd., is focused on developing automated growing systems for saffron and other exotic plants, with a proof of concept expected in the coming months.

Why It Matters

SATIVUS TECH CORP.'s widening losses and significant accumulated deficit raise substantial going concern doubts, directly impacting investor confidence and the company's ability to fund its ambitious agricultural technology development. The competitive landscape for automated indoor farming is intensifying, and SATT's ability to secure additional financing is critical to bringing its saffron growing system to market. Employees face uncertainty regarding the company's long-term viability, while potential customers and the broader market await a proven, scalable solution for high-yield exotic plant cultivation. Failure to secure funding could lead to a competitive disadvantage against better-capitalized rivals.

Risk Assessment

Risk Level: high — SATIVUS TECH CORP. has an accumulated deficit of $24,207 thousand as of September 30, 2025, and negative operating cash flow of $482 thousand for the nine months ended September 30, 2025. These factors, explicitly stated in Note 1.b, raise 'substantial doubt about the Company's ability to continue as a going concern,' indicating a high financial risk.

Analyst Insight

Investors should exercise extreme caution and consider avoiding SATIVUS TECH CORP. stock given the explicit 'going concern' warning and widening losses. Await concrete evidence of successful commercialization of their saffron technology and a clear path to profitability before considering any investment.

Financial Highlights

debt To Equity

N/A

revenue

N/A

operating Margin

N/A

total Assets

$569K

total Debt

N/A

net Income

-$403K

eps

N/A

gross Margin

N/A

cash Position

$159K

revenue Growth

N/A

Key Numbers

• $266K — Net Loss (Q3 2025) (Increased from a $2,070K net profit in Q3 2024)
• $599K — Net Loss (9M 2025) (Widened from $554K in 9M 2024)
• $24.2M — Accumulated Deficit (As of September 30, 2025, up from $23.6M at Dec 31, 2024)
• $482K — Negative Operating Cash Flow (For the nine months ended September 30, 2025)
• $159K — Cash and Cash Equivalents (As of September 30, 2025, up from $96K at Dec 31, 2024)
• $3.66M — Total Current Liabilities (As of September 30, 2025, up from $3.23M at Dec 31, 2024)
• 54% — Ownership of Saffron Tech (SATIVUS TECH CORP.'s stake in its key subsidiary)
• $169K — R&D Expenses (Q3 2025) (Increased from $93K in Q3 2024)
• $151K — G&A Expenses (Q3 2025) (Increased from $62K in Q3 2024)
• 4,215,571 — Shares Outstanding (As of November 17, 2025)

Key Players & Entities

• SATIVUS TECH CORP. (company) — registrant
• Saffron-Tech Ltd. (company) — wholly-owned subsidiary, 54% owned
• SEC (regulator) — Securities and Exchange Commission
• $266 thousand (dollar_amount) — net loss attributable to equity holders for Q3 2025
• $2,070 thousand (dollar_amount) — net profit attributable to equity holders for Q3 2024
• $24,207 thousand (dollar_amount) — accumulated deficit as of September 30, 2025
• $482 thousand (dollar_amount) — negative operating cash flow for nine months ended September 30, 2025
• $504 thousand (dollar_amount) — proceeds from issuance of shares of subsidiary
• $3,658 thousand (dollar_amount) — total current liabilities as of September 30, 2025

FAQ

Risk Factors

• Growing Accumulated Deficit [high — financial]: The company's accumulated deficit increased to $24,207 thousand as of September 30, 2025, from $23,608 thousand at December 31, 2024. This widening deficit indicates ongoing operational losses and a persistent inability to generate profits.
• Negative Operating Cash Flow [high — financial]: SATIVUS TECH CORP. experienced a negative operating cash flow of $482 thousand for the nine months ended September 30, 2025. This highlights the company's reliance on financing activities to sustain operations.
• Increasing Operating Expenses [medium — financial]: Both research and development (R&D) and general and administrative (G&A) expenses have significantly increased. R&D rose to $169 thousand in Q3 2025 from $93 thousand in Q3 2024, and G&A expenses climbed to $151 thousand from $62 thousand year-over-year. This surge in expenses, without corresponding revenue growth, exacerbates losses.
• Reliance on Financing for Cash [medium — financial]: The increase in cash and cash equivalents to $159 thousand from $96 thousand was primarily driven by $504 thousand in proceeds from share issuance in a subsidiary and $36 thousand from convertible loans. This demonstrates a dependence on external financing rather than operational cash generation.
• Rising Current Liabilities [medium — financial]: Total current liabilities increased to $3,658 thousand from $3,228 thousand, largely due to higher accounts payables and convertible loans. This could strain short-term liquidity if not managed effectively.
• Subsidiary Dependence and Proof of Concept Timeline [medium — operational]: The company's core business relies on its 54%-owned subsidiary, Saffron-Tech Ltd., which is developing automated growing systems. The company is awaiting a proof of concept, indicating that the core technology is still in development and not yet generating revenue.

Industry Context

SATIVUS TECH CORP. operates in the agricultural technology sector, focusing on automated growing systems for niche crops like saffron. This industry is characterized by innovation in controlled environment agriculture (CEA) and vertical farming, driven by demand for sustainable and efficient food production. However, it is also capital-intensive and faces challenges related to scaling, market adoption, and competition from established players and emerging technologies.

Regulatory Implications

As a technology company involved in agriculture, SATT may face evolving regulations related to food safety, environmental impact, and the use of automated systems. Compliance with these regulations, particularly as the company scales its operations or seeks broader market acceptance, could incur additional costs and operational complexities.

What Investors Should Do

1. Monitor the development and successful completion of the proof of concept for Saffron-Tech Ltd.'s automated growing systems, as this is critical for future revenue generation.
2. Analyze the sustainability of the company's current cash burn rate and its ability to secure further financing, given the negative operating cash flow and growing accumulated deficit.
3. Evaluate the strategy behind the significant increase in R&D and G&A expenses to determine if they are aligned with a clear path to profitability and market penetration.
4. Assess the terms and potential dilution impact of the outstanding convertible loans, which currently stand at $2,412 thousand.

Key Dates

• 2025-09-30: End of Q3 2025 — Reported a net loss of $266 thousand, a significant decline from a profit in the prior year, with increased operating expenses and a growing accumulated deficit.
• 2025-09-30: End of Nine Months 2025 — Net loss widened to $599 thousand, and operating cash flow was negative at $482 thousand, highlighting ongoing financial challenges.
• 2024-09-30: End of Q3 2024 — Reported a net profit of $2,070 thousand, indicating a substantial deterioration in profitability by Q3 2025.
• 2024-12-31: End of Fiscal Year 2024 — Accumulated deficit stood at $23,608 thousand, providing a baseline for the increase observed by September 30, 2025.

Glossary

Accumulated deficit

The cumulative net losses of a company that have not been offset by net profits. It represents the total losses incurred since the company's inception. (Indicates the company's long-term profitability and financial health. SATT's growing deficit suggests persistent unprofitability.)

Operating expenses

Costs incurred by a company in its normal course of business operations, excluding cost of goods sold. This includes R&D and G&A expenses. (An increase in operating expenses without a corresponding increase in revenue directly impacts net income. SATT's R&D and G&A expenses have risen significantly.)

Convertible loans

Debt instruments that can be converted into equity (shares) of the issuing company under certain conditions. (These represent a form of financing that can dilute existing shareholders if converted. SATT has $2,412 thousand in convertible loans outstanding.)

Non-controlling interests

The portion of equity interest in a subsidiary that is not attributable to the parent company. It represents the ownership stake held by external shareholders in the subsidiary. (Reflects the ownership structure of subsidiaries. SATT's net loss attributable to equity holders is after accounting for non-controlling interests.)

Proof of concept

A demonstration that a business idea, theory, or technology is feasible and can be implemented successfully. (SATT is awaiting a proof of concept for its subsidiary's automated growing systems, indicating the technology is still in a developmental stage.)

Year-Over-Year Comparison

Compared to the prior year's comparable period, SATIVUS TECH CORP. has seen a dramatic shift from profitability to significant losses. Q3 2025 reported a net loss of $266 thousand, a stark contrast to the $2,070 thousand net profit in Q3 2024. This downturn is driven by a substantial increase in operating expenses, with R&D and G&A nearly doubling year-over-year for the quarter. While cash reserves have increased due to financing activities, the company's accumulated deficit has also grown, and operating cash flow remains negative, indicating a worsening financial condition.

Key Financial Figures

• $0.001 — d 4,215,571 shares of its Common Stock, $0.001 par value, outstanding. When used in t
• $20.00 — nt by (y) the fixed conversion price of $20.00 or (z) 80% of the lowest the volume-wei
• $239 — the conversion feature in the amount of $239 was calculated with the following param
• $12.50 — Company's ordinary shares is less than $12.50 and (ii) there is no equity condition f
• $375 — the conversion feature in the amount of $375 was calculated with the following param
• $1.02 — etion, at the lower of a fixed price of $1.02 (the "Fixed Conversion Price") or 80% o
• $2.00 — of the Company at an exercise price of $2.00 per share, such exercise price is subje
• $58 — gust 7, 2020, and the Company allocated $58 to the BCF as a liability. As of Septem
• $76 — the conversion feature in the amount of $76 was calculated with the following param

Filing Documents

• sativus_i10q-093025.htm (10-Q) — 690KB
• sativus_ex3101.htm (EX-31.1) — 10KB
• sativus_ex3102.htm (EX-31.2) — 10KB
• sativus_ex3201.htm (EX-32.2) — 4KB
• sativus_ex3202.htm (EX-32.2) — 4KB
• 0001683168-25-008480.txt ( ) — 3922KB
• satt-20250930.xsd (EX-101.SCH) — 29KB
• satt-20250930_cal.xml (EX-101.CAL) — 34KB
• satt-20250930_def.xml (EX-101.DEF) — 105KB
• satt-20250930_lab.xml (EX-101.LAB) — 238KB
• satt-20250930_pre.xml (EX-101.PRE) — 213KB
• sativus_i10q-093025_htm.xml (XML) — 642KB

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 2 ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 6 ITEM 4.

CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES 6 PART II OTHER INFORMATION 7 ITEM 5. OTHER INFORMATION 7 ITEM 6. EXHIBITS 7

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Condensed Consolidated Financial Statements

Item 1. Condensed Consolidated Financial Statements SATIVUS TECH CORP. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of September 30, 2025 IN THOUSANDS OF U.S. DOLLARS INDEX Page Condensed Consolidated Balance Sheets as of September 30, 2025 (unaudited) and December 31, 2024 F-2 Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended September 30, 2025 (unaudited) and 2024 F-3 Condensed Consolidated Statements of Changes in Shareholders' Deficit for the Three Months Ended September 30, 2025 (unaudited) and 2024 (unaudited) F-4 Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 30, 2025 (unaudited) and 2024 (unaudited) F-5 Notes to Unaudited Consolidated Financial Statements F-6 – F-20 F-1 SATIVUS TECH CORP. CONDENSED CONSOLIDATED BALANCE SHEETS U.S. dollars in thousands, except share and per share data September 30, December 31, 2025 2024 (Unaudited) (Audited) ASSETS CURRENT ASSETS: Cash and cash equivalents $ 159 $ 96 Restricted cash 6 11 Accounts receivable 20 – Prepaid expenses and other receivables 46 24 Total current assets 231 131 NON-CURRENT ASSETS Property and equipment, net 338 427 Total non-current assets 338 427 Total assets $ 569 $ 558 LIABILITIES AND SHAREHOLDERS' DEFICIT CURRENT LIABILITIES Accounts payables $ 272 $ 65 Convertible loans 2,412 2,249 Fair value of convertible component in convertible loans 723 771 Other accounts liabilities 251 143 Total current liabilities 3,658 3,228 SHAREHOLDERS' DEFICIT Ordinary shares of $ 0.0001 par value Ordinary shares of $ 0.0001 par value Authorized: 500,000,000 shares at September 30, 2025 and December 31, 2024; Issued and Outstanding: 4,215,571 and 4,215,571 shares at September 30, 2025 and December 31, 2024, respectively 4 4 Additional Paid in capital 20,973 20,683 Accumulated deficit ( 24,207 ) ( 23,608 ) Shareholders' defici

View Full Filing

View this 10-Q filing on SEC EDGAR